BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 1999
View Archived Issues
New antimalarial korupensamines available for licensing from NIH
Read More
Diatide receives patent protection for novel cancer pain treatment
Read More
Oxis announces initial results of phase IIa clinical trial in ulcerative colitis
Read More
Metabolex enters into diabetes partnership with Parke-Davis
Read More
Cubist files IND to begin phase III clinical trials of daptomycin
Read More
Chromanylsulfonyl(thio)ureas in early development at Hoechst Marion Roussel
Read More
Sigma ligands synthesized at Jouveinal, evaluated and claimed for GI disorders
Read More
Novel cocaine analogues with promise in the treatment of cocaine addiction or overdose
Read More
Modulators of multidrug resistance described in patent literature by Ontogen
Read More
Protease inhibitors especially useful for osteoporosis, periodontitis and arthritis reported by SB
Read More
Taisho isolates antifungal compound from Streptomyces
Read More
New hope for AMD sufferers: verteporfin proves effective and safe in TAP investigation
Read More
Phase III study of PhotoPoint therapy in AMD enrolling patients
Read More
Positive adult meningitis study results reported for pleconaril
Read More
Genelabs and DuPont renew collaboration on novel compounds that regulate gene expression
Read More
Mexiletine effectively controls spasmodic torticollis in treatment-refractory patients
Read More
Adoptive immunotherapy for HIV infection shows potential in phase I study
Read More
Overview of three promising new antifungal drugs in development
Read More
Histamine H3 antagonist ciproxifan shows positive behavioral effects in animal models
Read More
ProScript and NCI enter collaboration for development of anticancer therapeutic
Read More
Shire updates R&D pipeline
Read More
Pharmacokinetic profile of edaravone, a novel antioxidant from Mitsubishi Chemical
Read More
Creative BioMolecules licenses neurotrophic protein from Cambridge NeuroScience
Read More
FDA approves home use of Lovenox in patients with potentially life-threatening blood clots
Read More
Ethyol for reducing radiation-induced xerostomia in head and neck cancer filed with FDA
Read More
Mycophenolate mofetil potentiates antiherpesvirus activity of aciclovir
Read More
Rhoxalpharma now operating as independent generic pharmaceutical company
Read More